Risk for latent tuberculosis infection reactivation among patients with psoriasis on biologics treatment: A meta-analysis

Risk for latent tuberculosis infection reactivation among patients with psoriasis on biologics treatment: A meta-analysis

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infection 2024-09, Vol.89 (3), p.106226, Article 106226
Hauptverfasser: Zhu, Xinyu, Pan, Xiaoyuan, Da, Meihong, Wang, Fei, Dong, Zhengbang
Format: Artikel
Sprache:eng
Schlagworte:
Biological Products - adverse effects
Biological Products - therapeutic use
Humans
Latent Tuberculosis - drug therapy
Psoriasis - drug therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 3
container_start_page 106226
container_title The Journal of infection
container_volume 89
creator Zhu, Xinyu
Pan, Xiaoyuan
Da, Meihong
Wang, Fei
Dong, Zhengbang
description
doi_str_mv 10.1016/j.jinf.2024.106226
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3078715100</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0163445324001609</els_id><sourcerecordid>3078715100</sourcerecordid><originalsourceid>FETCH-LOGICAL-c237t-c7591961e3c9cb59b895e762cc7c7865e22392d56c3f8480045b2c1023a5e7803</originalsourceid><addsrcrecordid>eNp9kM1O3DAUhS1UBFPgBVhUXnaTqX9iO666QaP-SUhICNaW47kZPCTx1HZA8_Y4nWmXrO691neO5A-ha0qWlFD5Zbvc-rFbMsLq8iAZkydoQQVnFVM1-4AWBeJVXQt-jj6mtCWEaK7lGTrnjW6kqtUC7e99esZdiLi3GcaM89RCdFMfkk-41IPLPow4gi3Li_172CGMG7wrR0kk_OrzE96lEL2dQwVofejDxruEcwnmoWBf8Q0eINvKjrbfF-4SnXa2T3B1nBfo8cf3h9Wv6vbu5-_VzW3lGFe5ckpoqiUF7rRrhW4bLUBJ5pxyqpECGOOarYV0vGvqhpBatMxRwrgtXEP4Bfp86N3F8GeClM3gk4O-tyOEKRlOVKOooGRG2QF1MaQUoTO76Acb94YSMys3WzMrN7Nyc1BeQp-O_VM7wPp_5J_jAnw7AFB--eIhmuSKOAdrH4tdsw7-vf43gtCT3A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3078715100</pqid></control><display><type>article</type><title>Risk for latent tuberculosis infection reactivation among patients with psoriasis on biologics treatment: A meta-analysis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Zhu, Xinyu ; Pan, Xiaoyuan ; Da, Meihong ; Wang, Fei ; Dong, Zhengbang</creator><creatorcontrib>Zhu, Xinyu ; Pan, Xiaoyuan ; Da, Meihong ; Wang, Fei ; Dong, Zhengbang</creatorcontrib><identifier>ISSN: 0163-4453</identifier><identifier>ISSN: 1532-2742</identifier><identifier>EISSN: 1532-2742</identifier><identifier>DOI: 10.1016/j.jinf.2024.106226</identifier><identifier>PMID: 38986747</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Biological Products - adverse effects ; Biological Products - therapeutic use ; Humans ; Latent Tuberculosis - drug therapy ; Psoriasis - drug therapy</subject><ispartof>The Journal of infection, 2024-09, Vol.89 (3), p.106226, Article 106226</ispartof><rights>2024 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c237t-c7591961e3c9cb59b895e762cc7c7865e22392d56c3f8480045b2c1023a5e7803</cites><orcidid>0009-0003-1038-6496</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jinf.2024.106226$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38986747$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhu, Xinyu</creatorcontrib><creatorcontrib>Pan, Xiaoyuan</creatorcontrib><creatorcontrib>Da, Meihong</creatorcontrib><creatorcontrib>Wang, Fei</creatorcontrib><creatorcontrib>Dong, Zhengbang</creatorcontrib><title>Risk for latent tuberculosis infection reactivation among patients with psoriasis on biologics treatment: A meta-analysis</title><title>The Journal of infection</title><addtitle>J Infect</addtitle><subject>Biological Products - adverse effects</subject><subject>Biological Products - therapeutic use</subject><subject>Humans</subject><subject>Latent Tuberculosis - drug therapy</subject><subject>Psoriasis - drug therapy</subject><issn>0163-4453</issn><issn>1532-2742</issn><issn>1532-2742</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1O3DAUhS1UBFPgBVhUXnaTqX9iO666QaP-SUhICNaW47kZPCTx1HZA8_Y4nWmXrO691neO5A-ha0qWlFD5Zbvc-rFbMsLq8iAZkydoQQVnFVM1-4AWBeJVXQt-jj6mtCWEaK7lGTrnjW6kqtUC7e99esZdiLi3GcaM89RCdFMfkk-41IPLPow4gi3Li_172CGMG7wrR0kk_OrzE96lEL2dQwVofejDxruEcwnmoWBf8Q0eINvKjrbfF-4SnXa2T3B1nBfo8cf3h9Wv6vbu5-_VzW3lGFe5ckpoqiUF7rRrhW4bLUBJ5pxyqpECGOOarYV0vGvqhpBatMxRwrgtXEP4Bfp86N3F8GeClM3gk4O-tyOEKRlOVKOooGRG2QF1MaQUoTO76Acb94YSMys3WzMrN7Nyc1BeQp-O_VM7wPp_5J_jAnw7AFB--eIhmuSKOAdrH4tdsw7-vf43gtCT3A</recordid><startdate>202409</startdate><enddate>202409</enddate><creator>Zhu, Xinyu</creator><creator>Pan, Xiaoyuan</creator><creator>Da, Meihong</creator><creator>Wang, Fei</creator><creator>Dong, Zhengbang</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0009-0003-1038-6496</orcidid></search><sort><creationdate>202409</creationdate><title>Risk for latent tuberculosis infection reactivation among patients with psoriasis on biologics treatment: A meta-analysis</title><author>Zhu, Xinyu ; Pan, Xiaoyuan ; Da, Meihong ; Wang, Fei ; Dong, Zhengbang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c237t-c7591961e3c9cb59b895e762cc7c7865e22392d56c3f8480045b2c1023a5e7803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biological Products - adverse effects</topic><topic>Biological Products - therapeutic use</topic><topic>Humans</topic><topic>Latent Tuberculosis - drug therapy</topic><topic>Psoriasis - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhu, Xinyu</creatorcontrib><creatorcontrib>Pan, Xiaoyuan</creatorcontrib><creatorcontrib>Da, Meihong</creatorcontrib><creatorcontrib>Wang, Fei</creatorcontrib><creatorcontrib>Dong, Zhengbang</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhu, Xinyu</au><au>Pan, Xiaoyuan</au><au>Da, Meihong</au><au>Wang, Fei</au><au>Dong, Zhengbang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk for latent tuberculosis infection reactivation among patients with psoriasis on biologics treatment: A meta-analysis</atitle><jtitle>The Journal of infection</jtitle><addtitle>J Infect</addtitle><date>2024-09</date><risdate>2024</risdate><volume>89</volume><issue>3</issue><spage>106226</spage><pages>106226-</pages><artnum>106226</artnum><issn>0163-4453</issn><issn>1532-2742</issn><eissn>1532-2742</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>38986747</pmid><doi>10.1016/j.jinf.2024.106226</doi><orcidid>https://orcid.org/0009-0003-1038-6496</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0163-4453
ispartof The Journal of infection, 2024-09, Vol.89 (3), p.106226, Article 106226
issn 0163-4453
1532-2742
1532-2742
language eng
recordid cdi_proquest_miscellaneous_3078715100
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Biological Products - adverse effects
Biological Products - therapeutic use
Humans
Latent Tuberculosis - drug therapy
Psoriasis - drug therapy
title Risk for latent tuberculosis infection reactivation among patients with psoriasis on biologics treatment: A meta-analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T09%3A18%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20for%20latent%20tuberculosis%20infection%20reactivation%20among%20patients%20with%20psoriasis%20on%20biologics%20treatment:%20A%20meta-analysis&rft.jtitle=The%20Journal%20of%20infection&rft.au=Zhu,%20Xinyu&rft.date=2024-09&rft.volume=89&rft.issue=3&rft.spage=106226&rft.pages=106226-&rft.artnum=106226&rft.issn=0163-4453&rft.eissn=1532-2742&rft_id=info:doi/10.1016/j.jinf.2024.106226&rft_dat=%3Cproquest_cross%3E3078715100%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3078715100&rft_id=info:pmid/38986747&rft_els_id=S0163445324001609&rfr_iscdi=true